Skip to content
2000
Volume 13, Issue 6
  • ISSN: 1567-2018
  • E-ISSN: 1875-5704

Abstract

Background: Tetrandrine (Tet), a kind of herbal medicine belonging to the family of bis-benzylisoquinoline alkaloid, has gained more attraction for its potential anti-tumor effects. However, its potential utilization in clinic is greatly hampered by the poor pharmacokinetcs profile due to its insolubility. Recently, biodegradable polymeric nanoparticles with amphilic copolymers as drug carriers have shown better bioavailability against tumor as promising tumor-targeted drug delivery system. Methods: In the current study, Tet-loaded nanoparticles (Tet-NPs) was prepared with amphiphilic block copolymer as drug carriers. The physiochemical characterization, in vitro and in vivo antitumor effect of nanoparticles were evaluated. Results: In vitro study demonstrated the superior cell inhibitory effect of Tet-NPs. Most importantly, the viability of cells exposed to Tet-NPs was significant lower than that of cells treated with free Tet at lower equivalent doses. Moreover, Tet- NPs induced apoptosis and inhibited the proliferation of cells more effectively than free did at the equivalent concentration. Western blot showed that the expression of anti-apoptotic protein Bcl-2, Bcl-XL was significantly promoted while the pro-apoptotic Bax was significantly inhibited by the treatment of Tet-NPs. Conclusion: Data from the current study suggested that Tet-NPs is a promising delivery nano-system for the treatment of osteosarcoma.

Loading

Article metrics loading...

/content/journals/cdd/10.2174/1567201813666160303104439
2016-09-01
2025-09-13
Loading full text...

Full text loading...

/content/journals/cdd/10.2174/1567201813666160303104439
Loading

  • Article Type:
    Research Article
Keyword(s): Drug delivery; Nanoparticles; Osteosarcoma; Tetrandrine
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test